Skip to main content

Table 1 Baseline characteristics of the transplant patients

From: Usefulness of speckle tracking echocardiography and biomarkers for detecting acute cellular rejection after heart transplantation

Characteristic

Heart transplant patients

n= 60

Male sex

34 (56.7%)

Age (years)

42.1± 11.5

Weight (kg)

61.3 ± 13.4

Height (cm)

162.5 ± 10.3

Body surface area (m2)

1.7 ± 0.2

Primary disease

 Chagasic cardiomyopathy

22 (36.7%)

 Idiopathic dilated cardiomyopathy

21 (35.0%)

 Ischemic cardiomyopathy

7 (11.7%)

 Valvular cardiomyopathy

5 (8.3%)

 Hypertensive cardiomyopathy

4 (6.7%)

 CTRCD

1 (1.6%)

Hypertension

12 (20.0%)

Diabetes

12 (20.0%)

Smoking

17 (28.3%)

Time since transplantation (months)

6

Medication

 Corticosteroid

63 (95.5%)

 Mycophenolate mofetil

62 (93.9%)

 Tacrolimus

45 (68.2%)

 Cyclosporine

21 (31.8%)

 Sirolimus

4 (6.1%)

 Azathioprine

4 (6.1%)

 Statin

61 (92.4%)

 CCB

56 (84.5%)

 Betablocker

11 (16.7%)

 ACEI/ARB

11 (16.7%)

  1. The values are presented as the mean (standard deviation) or number (percentage)
  2. CTRCD Cancer therapeutic-related cardiac dysfunction; ACEI angiotensin converting enzyme inhibitor; ARB aldosterone receptor blocker; CCB calcium channel blocker